Al Hammadi Company for Development and Investment reported a net profit of SAR 77.9 million for H1-2015, an 11.6 percent year-on-year increase on enhancement of the contractual terms with the company's customers and offering new services.
Item | 6m 2014 | 6m 2015 | Change |
---|---|---|---|
Revenues | 243.70 | 266.84 | 9.5 % |
Gross Income | 108.39 | 114.21 | 5.4 % |
Operating Income | 71.73 | 71.26 | (0.7 %) |
Net Income | 69.82 | 77.90 | 11.6 % |
Average Shares | 160.00 | 160.00 | - |
EPS (Riyals) | 0.44 | 0.49 | 11.6 % |
The company reported a net profit of SAR 36.9 million in Q2, compared to SAR 35.6 million in the same quarter last year. Its net profit, however, decreased quarter-on-quarter by 10 percent from SAR 41 million in Q1.
Item | Q2 2014 | Q2 2015 | Change |
---|---|---|---|
Revenues | 121.66 | 137.36 | 12.9 % |
Gross Income | 53.68 | 63.56 | 18.4 % |
Operating Income | 35.77 | 37.91 | 6.0 % |
Net Income | 35.60 | 36.89 | 3.6 % |
Average Shares | 160.00 | 160.00 | - |
EPS (Riyals) | 0.22 | 0.23 | 3.6 % |
Item | Q1 2015 | Q2 2015 | Change |
---|---|---|---|
Revenues | 129.48 | 137.36 | 6.1 % |
Gross Income | 50.64 | 63.56 | 25.5 % |
Operating Income | 33.35 | 37.91 | 13.7 % |
Net Income | 41.01 | 36.89 | (10.0 %) |
Average Shares | 160.00 | 160.00 | - |
EPS (Riyals) | 0.26 | 0.23 | (10.0 %) |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
Q1 2006 | - | - | - | - | - | - |
Q2 2006 | - | - | - | - | - | - |
Q3 2006 | - | - | - | - | - | - |
Q4 2006 | - | - | - | - | - | - |
2006 | - | - | - | - | - | - |
Q1 2007 | - | - | - | - | - | - |
Q2 2007 | - | - | - | - | - | - |
Q3 2007 | - | - | - | - | - | - |
Q4 2007 | - | - | - | - | - | - |
2007 | - | - | - | - | - | - |
Q1 2008 | - | - | - | - | - | - |
Q2 2008 | - | - | - | - | - | - |
Q3 2008 | - | - | - | - | - | - |
Q4 2008 | - | - | - | - | - | - |
2008 | - | - | - | - | - | - |
Q1 2009 | - | - | - | - | - | - |
Q2 2009 | - | - | - | - | - | - |
Q3 2009 | - | - | - | - | - | - |
Q4 2009 | - | - | - | - | - | - |
2009 | 309.88 | - | 125.79 | - | 80.95 | - |
Q1 2010 | - | - | - | - | - | - |
Q2 2010 | - | - | - | - | - | - |
Q3 2010 | - | - | - | - | - | - |
Q4 2010 | - | - | - | - | - | - |
2010 | 301.55 | (2.7 %) | 136.40 | 8.4 % | 87.88 | 8.6 % |
Q1 2011 | - | - | - | - | - | - |
Q2 2011 | - | - | - | - | - | - |
Q3 2011 | - | - | - | - | - | - |
Q4 2011 | - | - | - | - | - | - |
2011 | 330.66 | 9.7 % | 147.65 | 8.3 % | 92.15 | 4.9 % |
Q1 2012 | - | - | - | - | - | - |
Q2 2012 | - | - | - | - | - | - |
Q3 2012 | - | - | - | - | - | - |
Q4 2012 | - | - | - | - | - | - |
2012 | 378.68 | 14.5 % | 163.11 | 10.5 % | 92.34 | 0.2 % |
Q1 2013 | 104.84 | - | 47.34 | - | 30.09 | - |
Q2 2013 | 108.85 | - | 45.84 | - | 22.74 | - |
Q3 2013 | 96.26 | - | 36.81 | - | 19.02 | - |
Q4 2013 | 124.13 | - | 55.17 | - | 34.34 | - |
2013 | 434.08 | 14.6 % | 185.16 | 13.5 % | 112.10 | 21.4 % |
Q1 2014 | 122.04 | 16.4 % | 54.71 | 15.6 % | 35.96 | 19.5 % |
Q2 2014 | 121.66 | 11.8 % | 53.68 | 17.1 % | 35.77 | 57.3 % |
Q3 2014 | 108.83 | 13.1 % | 44.74 | 21.5 % | 24.77 | 30.3 % |
Q4 2014 | 129.43 | 4.3 % | 55.99 | 1.5 % | 34.52 | 0.5 % |
2014 | 481.96 | 11.0 % | 209.11 | 12.9 % | 130.95 | 16.8 % |
Q1 2015 | 129.48 | 6.1 % | 50.64 | (7.4 %) | 33.35 | (7.3 %) |
Q2 2015 | 137.36 | 12.9 % | 63.56 | 18.4 % | 37.91 | 6.0 % |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
2005 | - | - | - | - | - | - |
2006 | - | - | - | - | - | - |
2007 | - | - | - | - | - | - |
2008 | - | - | - | - | - | - |
2009 | 309.88 | - | 125.79 | - | 80.95 | - |
2010 | 301.55 | (2.7 %) | 136.40 | 8.4 % | 87.88 | 8.6 % |
2011 | 330.66 | 9.7 % | 147.65 | 8.3 % | 92.15 | 4.9 % |
2012 | 378.68 | 14.5 % | 163.11 | 10.5 % | 92.34 | 0.2 % |
2013 | 434.08 | 14.6 % | 185.16 | 13.5 % | 112.10 | 21.4 % |
2014 | 481.96 | 11.0 % | 209.11 | 12.9 % | 130.95 | 16.8 % |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
Q1 2006 | - | - | - | - | - | - |
Q2 2006 | - | - | - | - | - | - |
Q3 2006 | - | - | - | - | - | - |
Q4 2006 | - | - | - | - | - | - |
2006 | - | - | - | - | - | - |
Q1 2007 | - | - | - | - | - | - |
Q2 2007 | - | - | - | - | - | - |
Q3 2007 | - | - | - | - | - | - |
Q4 2007 | - | - | - | - | - | - |
2007 | - | - | - | - | - | - |
Q1 2008 | - | - | - | - | - | - |
Q2 2008 | - | - | - | - | - | - |
Q3 2008 | - | - | - | - | - | - |
Q4 2008 | - | - | - | - | - | - |
2008 | - | - | - | - | - | - |
Q1 2009 | - | - | - | - | - | - |
Q2 2009 | - | - | - | - | - | - |
Q3 2009 | - | - | - | - | - | - |
Q4 2009 | - | - | - | - | - | - |
2009 | 76.40 | - | 0.48 | - | 76.40 | 0.48 |
Q1 2010 | - | - | - | - | - | - |
Q2 2010 | - | - | - | - | - | - |
Q3 2010 | - | - | - | - | - | - |
Q4 2010 | - | - | - | - | - | - |
2010 | 79.87 | 4.5 % | 0.50 | - | 79.87 | 0.50 |
Q1 2011 | - | - | - | - | - | - |
Q2 2011 | - | - | - | - | - | - |
Q3 2011 | - | - | - | - | - | - |
Q4 2011 | - | - | - | - | - | - |
2011 | 89.94 | 12.6 % | 0.56 | - | 89.94 | 0.56 |
Q1 2012 | - | - | - | - | - | - |
Q2 2012 | - | - | - | - | - | - |
Q3 2012 | - | - | - | - | - | - |
Q4 2012 | - | - | - | - | - | - |
2012 | 94.27 | 4.8 % | 0.59 | - | 94.27 | 0.59 |
Q1 2013 | 29.83 | - | 0.19 | - | 29.83 | 0.19 |
Q2 2013 | 30.06 | - | 0.19 | - | 24.06 | 0.15 |
Q3 2013 | 18.32 | - | 0.11 | - | 18.32 | 0.11 |
Q4 2013 | 33.29 | - | 0.21 | - | 33.29 | 0.21 |
2013 | 111.50 | 18.3 % | 0.70 | - | 111.50 | 0.70 |
Q1 2014 | 34.23 | 14.7 % | 0.21 | - | 34.23 | 0.21 |
Q2 2014 | 35.60 | 18.4 % | 0.22 | - | 35.60 | 0.22 |
Q3 2014 | 25.42 | 38.7 % | 0.16 | - | 25.42 | 0.16 |
Q4 2014 | 33.71 | 1.2 % | 0.21 | - | 33.71 | 0.21 |
2014 | 128.95 | 15.6 % | 0.81 | - | 128.95 | 0.81 |
Q1 2015 | 41.01 | 19.8 % | 0.26 | 9.80 | 31.21 | 0.20 |
Q2 2015 | 36.89 | 3.6 % | 0.23 | - | 36.89 | 0.23 |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
2005 | - | - | - | - | - | - |
2006 | - | - | - | - | - | - |
2007 | - | - | - | - | - | - |
2008 | - | - | - | - | - | - |
2009 | 76.40 | - | 0.48 | - | 76.40 | 0.48 |
2010 | 79.87 | 4.5 % | 0.50 | - | 79.87 | 0.50 |
2011 | 89.94 | 12.6 % | 0.56 | - | 89.94 | 0.56 |
2012 | 94.27 | 4.8 % | 0.59 | - | 94.27 | 0.59 |
2013 | 111.50 | 18.3 % | 0.70 | - | 111.50 | 0.70 |
2014 | 128.95 | 15.6 % | 0.81 | - | 128.95 | 0.81 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2006 | - | - | - |
Q2 2006 | - | - | - |
Q3 2006 | - | - | - |
Q4 2006 | - | - | - |
2006 | - | - | - |
Q1 2007 | - | - | - |
Q2 2007 | - | - | - |
Q3 2007 | - | - | - |
Q4 2007 | - | - | - |
2007 | - | - | - |
Q1 2008 | - | - | - |
Q2 2008 | - | - | - |
Q3 2008 | - | - | - |
Q4 2008 | - | - | - |
2008 | - | - | - |
Q1 2009 | - | - | - |
Q2 2009 | - | - | - |
Q3 2009 | - | - | - |
Q4 2009 | - | - | - |
2009 | 40.59 % | 31.76 % | 24.65 % |
Q1 2010 | - | - | - |
Q2 2010 | - | - | - |
Q3 2010 | - | - | - |
Q4 2010 | - | - | - |
2010 | 45.23 % | 33.73 % | 26.49 % |
Q1 2011 | - | - | - |
Q2 2011 | - | - | - |
Q3 2011 | - | - | - |
Q4 2011 | - | - | - |
2011 | 44.65 % | 31.79 % | 27.20 % |
Q1 2012 | - | - | - |
Q2 2012 | - | - | - |
Q3 2012 | - | - | - |
Q4 2012 | - | - | - |
2012 | 43.07 % | 27.97 % | 24.89 % |
Q1 2013 | - | - | - |
Q2 2013 | - | - | - |
Q3 2013 | - | - | - |
Q4 2013 | 42.66 % | 27.60 % | 24.31 % |
2013 | 42.66 % | 28.96 % | 25.69 % |
Q1 2014 | 42.66 % | 27.85 % | 24.35 % |
Q2 2014 | 43.18 % | 29.90 % | 26.17 % |
Q3 2014 | 43.70 % | 30.34 % | 26.97 % |
Q4 2014 | 43.39 % | 30.09 % | 26.75 % |
2014 | 43.39 % | 30.07 % | 26.75 % |
Q1 2015 | 41.90 % | 29.13 % | 25.73 % |
Q2 2015 | 42.55 % | 28.68 % | 25.19 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2005 | - | - | - |
2006 | - | - | - |
2007 | - | - | - |
2008 | - | - | - |
2009 | 40.59 % | 31.76 % | 24.65 % |
2010 | 45.23 % | 33.73 % | 26.49 % |
2011 | 44.65 % | 31.79 % | 27.20 % |
2012 | 43.07 % | 27.97 % | 24.89 % |
2013 | 42.66 % | 28.96 % | 25.69 % |
2014 | 43.39 % | 30.07 % | 26.75 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2006 | - | - | - |
Q2 2006 | - | - | - |
Q3 2006 | - | - | - |
Q4 2006 | - | - | - |
Q1 2007 | - | - | - |
Q2 2007 | - | - | - |
Q3 2007 | - | - | - |
Q4 2007 | - | - | - |
Q1 2008 | - | - | - |
Q2 2008 | - | - | - |
Q3 2008 | - | - | - |
Q4 2008 | - | - | - |
Q1 2009 | - | - | - |
Q2 2009 | - | - | - |
Q3 2009 | - | - | - |
Q4 2009 | - | - | - |
Q1 2010 | - | - | - |
Q2 2010 | - | - | - |
Q3 2010 | - | - | - |
Q4 2010 | - | - | - |
Q1 2011 | - | - | - |
Q2 2011 | - | - | - |
Q3 2011 | - | - | - |
Q4 2011 | - | - | - |
Q1 2012 | - | - | - |
Q2 2012 | - | - | - |
Q3 2012 | - | - | - |
Q4 2012 | - | - | - |
Q1 2013 | 45.15 % | 31.89 % | 28.45 % |
Q2 2013 | 42.11 % | 24.00 % | 22.10 % |
Q3 2013 | 38.24 % | 23.34 % | 19.03 % |
Q4 2013 | 44.45 % | 30.42 % | 26.82 % |
Q1 2014 | 44.83 % | 32.21 % | 28.04 % |
Q2 2014 | 44.12 % | 32.25 % | 29.26 % |
Q3 2014 | 41.11 % | 26.05 % | 23.36 % |
Q4 2014 | 43.26 % | 29.45 % | 26.04 % |
Q1 2015 | 39.11 % | 28.49 % | 24.10 % |
Q2 2015 | 46.28 % | 30.21 % | 26.86 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
Q1 2006 | - | - | - | - |
Q2 2006 | - | - | - | - |
Q3 2006 | - | - | - | - |
Q4 2006 | - | - | - | - |
Q1 2007 | - | - | - | - |
Q2 2007 | - | - | - | - |
Q3 2007 | - | - | - | - |
Q4 2007 | - | - | - | - |
Q1 2008 | - | - | - | - |
Q2 2008 | - | - | - | - |
Q3 2008 | - | - | - | - |
Q4 2008 | - | - | - | - |
Q1 2009 | - | - | - | - |
Q2 2009 | - | - | - | - |
Q3 2009 | - | - | - | - |
Q4 2009 | - | - | - | - |
Q1 2010 | - | - | - | - |
Q2 2010 | - | - | - | - |
Q3 2010 | - | - | - | - |
Q4 2010 | - | - | - | - |
Q1 2011 | - | - | - | - |
Q2 2011 | - | - | - | - |
Q3 2011 | - | - | - | - |
Q4 2011 | - | - | - | - |
Q1 2012 | - | - | - | - |
Q2 2012 | - | - | - | - |
Q3 2012 | - | - | - | - |
Q4 2012 | - | - | - | - |
Q1 2013 | 160.00 | - | - | 3.74 |
Q2 2013 | 160.00 | - | - | 3.67 |
Q3 2013 | 160.00 | - | - | 3.78 |
Q4 2013 | 160.00 | 0.70 | 0.66 | 3.66 |
Q1 2014 | 160.00 | 0.72 | 0.69 | 3.87 |
Q2 2014 | 160.00 | 0.76 | 0.76 | 7.88 |
Q3 2014 | 160.00 | 0.80 | 0.80 | 8.04 |
Q4 2014 | 160.00 | 0.81 | 0.81 | 8.25 |
Q1 2015 | 160.00 | 0.85 | 0.79 | 8.51 |
Q2 2015 | 160.00 | 0.86 | 0.80 | 8.27 |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2005 | - | - | - | - |
2006 | - | - | - | - |
2007 | - | - | - | - |
2008 | - | - | - | - |
2009 | 160.00 | 0.48 | 0.48 | 2.35 |
2010 | 160.00 | 0.50 | 0.50 | 2.78 |
2011 | 160.00 | 0.56 | 0.56 | 2.96 |
2012 | 160.00 | 0.59 | 0.59 | 3.55 |
2013 | 160.00 | 0.70 | 0.70 | 3.66 |
2014 | 160.00 | 0.81 | 0.81 | 8.25 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
Q1 2006 | - | - | - |
Q2 2006 | - | - | - |
Q3 2006 | - | - | - |
Q4 2006 | - | - | - |
Q1 2007 | - | - | - |
Q2 2007 | - | - | - |
Q3 2007 | - | - | - |
Q4 2007 | - | - | - |
Q1 2008 | - | - | - |
Q2 2008 | - | - | - |
Q3 2008 | - | - | - |
Q4 2008 | - | - | - |
Q1 2009 | - | - | - |
Q2 2009 | - | - | - |
Q3 2009 | - | - | - |
Q4 2009 | - | - | - |
Q1 2010 | - | - | - |
Q2 2010 | - | - | - |
Q3 2010 | - | - | - |
Q4 2010 | - | - | - |
Q1 2011 | - | - | - |
Q2 2011 | - | - | - |
Q3 2011 | - | - | - |
Q4 2011 | - | - | - |
Q1 2012 | - | - | - |
Q2 2012 | - | - | - |
Q3 2012 | - | - | - |
Q4 2012 | - | - | - |
Q1 2013 | - | - | - |
Q2 2013 | - | - | - |
Q3 2013 | - | - | - |
Q4 2013 | - | - | - |
Q1 2014 | - | - | - |
Q2 2014 | - | - | - |
Q3 2014 | 51.42 | 51.42 | 5.14 |
Q4 2014 | 48.92 | 48.92 | 4.78 |
Q1 2015 | 51.53 | 55.54 | 5.14 |
Q2 2015 | 54.13 | 58.30 | 5.61 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2005 | - | - | - |
2006 | - | - | - |
2007 | - | - | - |
2008 | - | - | - |
2009 | - | - | - |
2010 | - | - | - |
2011 | - | - | - |
2012 | - | - | - |
2013 | - | - | - |
2014 | 48.92 | 48.92 | 4.78 |
2015
2015
Period | healthy services and other | Pharmaceutical sales revenue - Pharmacies |
---|
Period | healthy services and other | Pharmaceutical sales revenue - Pharmacies |
---|---|---|
2010 | 224.05 | 77.50 |
2011 | 244.33 | 86.33 |
2012 | 274.90 | 103.78 |
2013 | 317.00 | 117.11 |
2014 | 360.30 | 121.61 |
Item | Q2 2015 (e) | Q2 2015 (a) | Change |
---|---|---|---|
Average | 35.00 | 36.89 | 5.40 % |
Item | Q2 2015 (e) | Q2 2015 (a) | Change |
---|---|---|---|
Al Rajhi Capital | 35.00 | 36.89 | 5.4 % |
Current | |
Market Cap (M Riyal) | 6,400.00 |
Enterprise Value (EV) (M) | 6,161.92 |
Shares Outstanding ((M)) | 160.00 |
EPS ( Riyal) (TTM) | 2.04 |
Book Value (BV) ( Riyal) | 12.11 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | 24.20 |
P/E (TTM) | 19.62 |
Price/book | 3.30 |
Return on Average Assets (%) (TTM) | 12.5 |
Return on Average Equity (%) (TTM) | 17.3 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}